Sunshine Biopharma Share Price Today
(NASDAQ: SBFM)

Name: Sunshine Biopharma Share Price Today (NASDAQ: SBFM) - Sunshine Biopharma Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Sunshine Biopharma share price is $2.37 & ₹206.12 as on 6 Mar 2025, 2.30 'hrs' IST

$2.37

▲

0.23

(10.8%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Sunshine Biopharma share price in Dollar and Rupees. Guide to invest in Sunshine Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sunshine Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Sunshine Biopharma share price movements

Today's Low: $2.22
Today's High: $2.37
$2.37
6.35%
Downside
Day's Volatility :6.35%
Upside
0.0%
52 Weeks Low: $2.11
52 Weeks High: $285.00
$2.37
11.16%
Downside
52 Weeks Volatility :99.26%
Upside
99.17%

Sunshine Biopharma (SBFM) Returns

Period	Sunshine Biopharma Inc	Index (Russel 2000)
3 Months	-33.78%	0.0%
6 Months	-26.24%	0.0%
1 Year	-98.38%	0.0%
3 Years	-99.93%	-11.6%

Sunshine Biopharma (SBFM) Key Statistics

in dollars & INR

Previous Close	$2.139
Open	$2.18
Today's High	$2.37
Today's Low	$2.2194
Market Capitalization	$6.3M
Today's Volume	$4.2K
52 Week High	$285.0
52 Week Low	$2.1056
Revenue TTM	$33.0M
EBITDA	$-4.8M
Earnings Per Share (EPS)	$-127.9
Profit Margin	-12.82%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.98%

How to invest in Sunshine Biopharma Stock (SBFM) from India?

It is very easy for Indian residents to invest directly in Sunshine Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sunshine Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sunshine Biopharma or SBFM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sunshine Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sunshine Biopharma shares which would translate to 0.367 fractional shares of Sunshine Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sunshine Biopharma, in just a few clicks!

Returns in Sunshine Biopharma (SBFM) for Indian investors in Rupees

The Sunshine Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Sunshine Biopharma investment value today

Current value as on today

₹6,758

Returns

₹93,242

(-93.24%)

Returns from Sunshine Biopharma Stock

₹98,205 (-98.2%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Sunshine Biopharma (SBFM)

-56%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Sunshine Biopharma Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sunshine Biopharma

Connective Capital Management LLC
0.42%
Morgan Stanley - Brokerage Accounts
0.28%
UBS Group AG
0.03%
SBI Securities Co Ltd
0.03%

Analyst Recommendation on Sunshine Biopharma

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Sunshine Biopharma(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Sunshine Biopharma Stock (SBFM)

What analysts predicted

Upside of 12558.23%

Target:

$300.00

Current:

$2.37

Insights on Sunshine Biopharma Stock (Ticker Symbol: SBFM)

Price Movement
In the last 1 year, SBFM stock has moved down by -98.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 9.30M → 8.43M (in $), with an average decrease of 9.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -494.3K → -1.19M (in $), with an average decrease of 142.3% per quarter
SBFM vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 195.7%
SBFM vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 238.1%
Price to Sales
ForSBFM every $1 of sales, investors are willing to pay $0.0, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

SBFM Sunshine Biopharma Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$447.2K	-
Net Income	$-2.2M	↑ 107.28%
Net Profit Margin	-482.15%	-

	FY19	Y/Y Change
Revenue	$21.1K	↓ 95.28%
Net Income	$-1.5M	↓ 32.22%
Net Profit Margin	-6.9K%	↓ 6437.22%

	FY20	Y/Y Change
Revenue	$71.4K	↑ 238.1%
Net Income	$-897.7K	↓ 38.58%
Net Profit Margin	-1.3K%	↑ 5662.29%

	FY21	Y/Y Change
Revenue	$228.4K	↑ 219.88%
Net Income	$-12.8M	↑ 1322.02%
Net Profit Margin	-5.6K%	↓ 4331.28%

	FY22	Y/Y Change
Revenue	$4.3M	↑ 1802.41%
Net Income	$-26.7M	↑ 109.51%
Net Profit Margin	-615.44%	↑ 4972.92%

	FY23	Y/Y Change
Revenue	$24.1M	↑ 454.42%
Net Income	$-4.5M	↓ 83.15%
Net Profit Margin	-18.7%	↑ 596.74%

	Q2 FY23	Q/Q Change
Revenue	$5.6M	↑ 13.62%
Net Income	$-902.1K	↓ 47.01%
Net Profit Margin	-16.22%	↑ 18.57%

	Q3 FY23	Q/Q Change
Revenue	$6.0M	↑ 7.14%
Net Income	$-651.5K	↓ 27.78%
Net Profit Margin	-10.94%	↑ 5.28%

	Q4 FY23	Q/Q Change
Revenue	$7.7M	↑ 28.91%
Net Income	$-1.3M	↑ 91.87%
Net Profit Margin	-16.28%	↓ 5.34%

	Q1 FY24	Q/Q Change
Revenue	$7.5M	↓ 1.81%
Net Income	$-1.3M	↑ 2.7%
Net Profit Margin	-17.02%	↓ 0.74%

	Q2 FY24	Q/Q Change
Revenue	$9.3M	↑ 23.37%
Net Income	$-494.3K	↓ 61.5%
Net Profit Margin	-5.31%	↑ 11.71%

	Q3 FY24	Q/Q Change
Revenue	$8.4M	↓ 9.33%
Net Income	$-1.2M	↑ 142.32%
Net Profit Margin	-14.2%	↓ 8.89%

	FY18	Y/Y Change
Profit	$56.1K	-

	FY19	Y/Y Change
Profit	$10.1K	↓ 82.05%

	FY20	Y/Y Change
Profit	$45.6K	↑ 352.42%

	FY21	Y/Y Change
Profit	$110.6K	↑ 142.73%

	FY22	Y/Y Change
Profit	$1.7M	↑ 1434.03%

	FY23	Y/Y Change
Profit	$8.3M	↑ 391.53%

	Q2 FY23	Q/Q Change
Profit	$2.0M	↑ 6.82%

	Q3 FY23	Q/Q Change
Profit	$2.0M	↑ 1.92%

	Q4 FY23	Q/Q Change
Profit	$2.5M	↑ 26.9%

	Q1 FY24	Q/Q Change
Profit	$2.3M	↓ 8.47%

	Q2 FY24	Q/Q Change
Profit	$2.3M	↓ 0.27%

	Q3 FY24	Q/Q Change
Profit	$2.8M	↑ 21.52%

	FY18	Y/Y Change
Operating Cash Flow	$-512.8K	↓ 5.65%
Investing Cash Flow	$-13.9K	↓ 83.44%
Financing Cash Flow	$527.6K	↓ 21.33%

	FY19	Y/Y Change
Operating Cash Flow	$-495.8K	↓ 3.32%
Investing Cash Flow	$-15.3K	↑ 9.84%
Financing Cash Flow	$442.3K	↓ 16.18%

	FY20	Y/Y Change
Operating Cash Flow	$-657.3K	↑ 32.57%
Investing Cash Flow	$-1.2K	↓ 92.2%
Financing Cash Flow	$1.6M	↑ 263.65%

	FY21	Y/Y Change
Operating Cash Flow	$-1.8M	↑ 178.28%
Investing Cash Flow	$-14.6M	↑ 1227388.66%
Financing Cash Flow	$2.9M	↑ 80.61%

	FY22	Y/Y Change
Operating Cash Flow	$-5.2M	↑ 186.93%
Investing Cash Flow	$-14.6M	↑ 0.0%
Financing Cash Flow	$39.5M	↑ 1258.68%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.8M	↑ 104.21%
Investing Cash Flow	$-259.5K	↑ 0.0%
Financing Cash Flow	$4.1M	↓ 853.85%

Sunshine Biopharma Technicals Summary

Sell

Neutral

Buy

Sunshine Biopharma is currently in a neutral trading position according to technical analysis indicators.

Sunshine Biopharma (SBFM) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sunshine Biopharma Inc	-19.28%	-26.24%	-98.38%	-99.93%	-99.99%
Intra-cellular Therapies, Inc.	3.42%	81.22%	98.76%	146.55%	588.92%
Haleon Plc Spon Ads	12.55%	3.39%	28.09%	43.99%	43.99%
Zoetis Inc.	-1.19%	-8.94%	-7.43%	-9.67%	30.97%
Neurocrine Biosciences Inc.	-24.64%	-6.68%	-14.47%	28.61%	27.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sunshine Biopharma Inc	0.0	NA	0.0	0.0	-0.18	-0.11	NA	12.52
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.68	26.68	1.5	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.8	34.8	0.27	6.47	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sunshine Biopharma Inc	Buy	$6.3M	-99.99%	0.0	-12.82%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.92%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$48.2B	43.99%	26.68	12.84%
Zoetis Inc.	Buy	$76.1B	30.97%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.3B	27.88%	34.8	14.49%

About Sunshine Biopharma

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.

Organization	Sunshine Biopharma
Employees	44
CEO	Dr. Steve N. Slilaty Ph.D.
Industry	Pharmaceuticals: Other

Management People of Sunshine Biopharma

Name	Title
Dr. Steve N. Slilaty Ph.D.	Chairman, President & CEO
Mr. Camille Sebaaly	CFO & Secretary
Dr. Abderrazzak Merzouki	COO & Director
Mr. Malek Chamoun	Chief Development Officer
Mr. Michel Roy	Chief Commercial Officer
Mr. Robert G. Ferreira	President of Sunshine Bio Investments Inc

Important FAQs about investing in SBFM Stock from India :

What is Sunshine Biopharma share price today?

Sunshine Biopharma share price today stands at $2.37, Open: $2.18 ; Previous Close: $2.14 ; High: $2.37 ; Low: $2.22 ; 52 Week High: $285.00 ; 52 Week Low: $2.11.

The stock opens at $2.18, after a previous close of $2.14. The stock reached a daily high of $2.37 and a low of $2.22, with a 52-week high of $285.00 and a 52-week low of $2.11.

Can Indians buy Sunshine Biopharma shares?

Yes, Indians can invest in the Sunshine Biopharma (SBFM) from India.

With INDmoney, you can buy Sunshine Biopharma at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sunshine Biopharma at zero transaction cost.

How can I buy Sunshine Biopharma shares from India?

It is very easy to buy Sunshine Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sunshine Biopharma (SBFM) be purchased?

Yes, you can buy fractional shares of Sunshine Biopharma with INDmoney app.

What are the documents required to start investing in Sunshine Biopharma stocks?

To start investing in Sunshine Biopharma, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.